Please sign in to follow a disease.
Syndromic craniosynostosis
MONDO:0015338A craniosynostosis that is part of a larger syndrome.
Also known as: syndrome associated with craniosynostosis, syndromic craniosynostosis
22 clinical trials for this condition and its sub-types, 1 tagged with Syndromic craniosynostosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Syndromic craniosynostosis
-
Acrocephalosyndactyly 0 trials · 13 incl. sub-types
4 sub-types
- Apert syndrome 11 trials Sub-types →
- Saethre-Chotzen syndrome 3 trials
- Acrocephalopolysyndactyly 0 trials · 1 incl. sub-types Sub-types →
- Jackson-Weiss syndrome 0 trials
-
Antley-Bixler syndrome 2 trials
-
Muenke syndrome 2 trials
-
Crouzon syndrome 1 trial
2 sub-types
- Bazopoulou Kyrkanidou syndrome 0 trials
- Cote katsantoni syndrome 0 trials
-
Shprintzen-Goldberg syndrome 1 trial
-
Pseudoaminopterin syndrome 1 trial
-
Baller-Gerold syndrome 0 trials
-
C syndrome 0 trials
-
Curry-Jones syndrome 0 trials
-
Hunter-McAlpine craniosynostosis 0 trials
-
Lowry-MacLean syndrome 0 trials
-
Summitt syndrome 0 trials
-
TCF12-related craniosynostosis 0 trials
-
Weiss-Kruszka syndrome 0 trials
-
Acrocephalopolydactyly 0 trials
-
Cranioectodermal dysplasia 0 trials
7 sub-types
- Cranioectodermal dysplasia 1 0 trials
- Cranioectodermal dysplasia 2 0 trials
- Cranioectodermal dysplasia 3 0 trials
- Cranioectodermal dysplasia 4 0 trials
- Cranioectodermal dysplasia 5 0 trials
- Cranioectodermal dysplasia 6 0 trials
- Short-rib thoracic dysplasia 16 with or without polydactyly 0 trials
-
Craniomicromelic syndrome 0 trials
-
Craniosynostosis 2 0 trials
-
Craniosynostosis 4 0 trials
-
Craniosynostosis, Philadelphia type 0 trials
-
Craniosynostosis-cataract syndrome 0 trials
-
Craniotelencephalic dysplasia 0 trials
-
Familial scaphocephaly syndrome 0 trials
2 sub-types
-
Trigonocephaly-broad thumbs syndrome 0 trials
Most studied deeper sub-types
-
New bladder cancer drug delivery system tested in small japanese study
Disease control OngoingThis early-stage study tests a new treatment called TAR-210 in 5 Japanese patients with a type of bladder cancer that has specific genetic changes (FGFR mutations). The treatment is placed directly into the bladder to deliver the drug erdafitinib. The main goal is to see if it is…
Phase 1 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a pill target Hard-to-Treat bile duct cancers? a new drug puts FGFR2 mutations to the test
Disease control OngoingThis early-stage trial is testing an experimental oral drug, TYRA-200, in people with advanced bile duct cancer (intrahepatic cholangiocarcinoma) and other solid tumors that have specific changes in the FGFR2 gene. The study aims to find a safe and effective dose and to see wheth…
Phase 1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Blood pressure drug may offer clues to chronic pain relief
Knowledge-focused OngoingThis early-phase study looks at whether a common blood pressure drug, hydrochlorothiazide, can affect chronic pain in people who already have a spinal cord stimulator implant. About 36 adults with chronic low back pain and high blood pressure will take the drug or a placebo for t…
Early phase 1 • Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Hidden danger in the ICU: study reveals how often staff face assault
Knowledge-focused OngoingThis study examines how often healthcare workers in a hospital's intensive care unit (ICU) experience physical, verbal, or sexual assaults from patients or their relatives. Researchers will review medical records of 865 adults who were in the ICU and had a reported incident of vi…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for hidden genes behind aortic aneurysms
Knowledge-focused OngoingThis study aims to uncover the genetic roots of aortic aneurysms and valve disease by analyzing tissue and blood samples from 3,000 participants. Researchers will look for new disease-causing genes and factors that affect disease severity. The goal is to build a biorepository to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC